Status:
RECRUITING
Matching Treatments to Cognitive Deficits in Offenders With Substance Use Disorders
Lead Sponsor:
The Mind Research Network
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Antisocial Behavior
Eligibility:
MALE
18-55 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to investigate the effect of two types of cognitive remediation training on real-world behavioral outcomes including substance use, institutional adjustment, and rec...
Detailed Description
Prior research has identified two subtypes of antisocial offenders, typified by distinct dysfunctional cognitive emotion interactions undermining self-regulation. One subtype is characterized by an at...
Eligibility Criteria
Inclusion
- Currently incarcerated
- No uncorrectable auditory or visual deficits
- Able to speak and/or understand English
- 5th grade reading level or higher
- IQ score = 80 or above
- Lifetime history of substance use disorder based on DSM criteria
- No history of dementia or other cognitive disability
- No indication of current psychotic disorder
- No major medical illness or CNS disease
- Scores from the Psychopathy Checklist-Revised (PCL-R) meet criteria for one of the designated treatment groups
Exclusion
- \-
Key Trial Info
Start Date :
March 18 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2029
Estimated Enrollment :
288 Patients enrolled
Trial Details
Trial ID
NCT06981351
Start Date
March 18 2025
End Date
May 31 2029
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mind Research Network/Lovelace Biomedical Research Institute
Albuquerque, New Mexico, United States, 87106